Fighting for life everywhere she goes.
Digging into the "why" of racial disparity in kidney cancer outcomes.
Fox Chase Cancer Center’s urologic oncology group shares an educational video that provides instruction on how to perform a device-free, free-handed transperineal prostate biopsy.
Jelmyto provides an alternative treatment option for low-grade UTUC and may spare some patients from nephrectomy. A recent study of the treatment showed a 58% complete response rate.
Unraveling the genome to reshape cancer care.
Researchers at Fox Chase Cancer Center have developed a model that predicts disease recurrence and survival in patients with intermediate- and high-risk localized kidney cancer more accurately than existing prognostic models.
Fox Chase’s Alexander Kutikov, MD, FACS, is leading an international effort to create a centralized, streamlined, point-of-care resource for the management of adrenal masses.
An American Society of Clinical Oncology (ASCO) collaborative report named the use of molecular profiling the top advance of 2021, but also identified priority areas for future research.
Amoroso is part of the nurse-led dedicated intravesical clinic that helps optimize treatment for patients and workflow for other physicians and nurses.
Two new collaborative publications focus on treatment decisions for patients with renal masses.
Fox Chase Cancer Center is now offering patients a more convenient and effective method of prostate cancer diagnosis—the ExactVu™ micro-ultrasound system.
Three members of Fox Chase Cancer Center’s Genitourinary Cancer Program – Elizabeth Plimack, MD, MS; Alexander Kutikov, MD, FACS; and Benjamin Miron, MD -- have gained national recognition for their work advancing the care of patients ...
As patient care adapted to the restrictions of the COVID-19 pandemic, Farrell continued to ensure that patients had access to cutting-edge care.
Evaluating the current standards of care for cystectomy yielded interesting results on when it is most appropriate.
The COVID-19 pandemic has precipitated many changes in medical practice. View this symposium, where the Fox Chase Cancer Center genitourinary (GU) oncology team will discuss the impact of the pandemic on GU cancer care as well as the latest ...
The clinicians in Fox Chase Cancer Center’s Division of Urology and Urologic Oncology are accustomed to providing patients with specialized care and advanced treatment, but they are also dedicated to sharing their experience and educating ...
Robot-assisted renal surgery using retroperitoneal access requires substantial technical expertise and experience, and the urologic oncology team at Fox Chase Cancer Center is one of few local centers of excellence that offers it as a treatment option.
The urologic oncology team at Fox Chase Cancer Center continues to foster important international relationships in its pursuit of optimal surgical strategies for kidney cancer.
Benjamin T. Ristau, MD, MHA, Randall A. Lee, MD, and Alexander Kutikov, MD, FACS, present a retroperitoneoscopic robot-assisted partial nephrectomy on a morbidly obese patient.
Over the last decade, dozens of predictive models have been developed to improve on the ability of stage, grade and type to predict recurrence. Unfortunately, many of the prediction models used by clinicians to guide patient care and clinical ...
Treatment approaches for bladder and prostate cancers have undergone rapid evolution in the last few years. Some patients can now safely delay or avoid surgery entirely and preserve their quality of life with positive oncological outcomes. ...